Price T Rowe Associates Inc /Md/ - Dec 31, 2024 SCHEDULE 13G Report for CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX)

Filing Manager: PRICE T ROWE ASSOCIATES INC /MD/
Reporting Manager: T. Rowe Price Associates, Inc.
Security: CELLDEX THERAPEUTICS INC COMMON STOCK
Symbol: CLDX
Shares outstanding: 65.9M shares
Disclosed Ownership: 3.56M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 09:44 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
T. Rowe Price Associates, Inc.	5.4%	3.56M	3.48M	0	Ellen York	Vice President